SynercidActive Ingredient(s): Dalfopristin + Quinupristin
FDA Approved: * September 21, 1999
Pharm Company: * KING PHARMS
Quinupristin/dalfopristin, or quinupristin-dalfopristin, (pronunciation: kwi NYOO pris tin / dal FOE pris tin) (trade name Synercid) is a combination of two antibiotics used to treat infections by staphylococci and by vancomycin-resistant Enterococcus faecium. Quinupristin and dalfopristin are both streptogramin antibiotics, derived from pristinamycin. Quinupristin is derived from pristinamycin IA; dalfopristin from pristinamycin IIA. They are combined in a weight-to-weight ratio of 30% quinu... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.
Synercid Intravenous Injection, Powder, Lyophilized, for SolutionNDC: 61570-260
Pfizer Laboratories Div Pfizer Inc